DCGI gives EUA nod to SII’s Covovax for 12-17 years’ age group
It is the fourth vaccine to receive the regulator's nod for use among those below 18 years
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.